ROHTO PHARMACEUTICAL CO.,LTD., First Half Ordinary Profit Decreases by 18%, July-September Ordinary Profit Decreases by 39%

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Wed Nov 13, 2024 3:30 pm JST Earnings

4527 ROHTO PHARMACEUTICAL CO.,LTD. 【J-GAAP】

Earnings Report

ROHTO PHARMACEUTICAL CO.,LTD. <4527> [TSE-P] announced its financial results after the market closed on November 13th (15:30). The consolidated ordinary profit for the cumulative second quarter of the fiscal year ending March 2025 (April to September) decreased by 18.0% from the same period last year to 18.5 billion yen. The progress rate against the 44.2 billion yen full-year plan was 42.1%, also falling below the five-year average of 48.5%.

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the October to March period (second half) is expected to grow by 29.6% from the same period last year, reaching 25.6 billion yen.

In the most recent three-month period, from July to September (2Q), the consolidated ordinary profit dropped to 6.31 billion yen, a 39.5% decrease compared to the same period last year. The operating profit margin significantly dropped from 14.5% in the same period last year to 8.5%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Sep, 2022	110,313	16,269	17,963	13,192	57.8	50.5	Nov 10, 2022	J-GAAP
Apr - Sep, 2023	127,869	20,966	22,678	16,594	72.7	53.4	Nov 10, 2023	J-GAAP
Apr - Sep, 2024	139,082	17,791	18,590	12,921	56.6	42.1	Nov 13, 2024	J-GAAP
YoY	+8.8%	-15.1%	-18.0%	-22.1%	-22.1%

First Half Results vs. Previous Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Apr - Sep, 2024 Guidance	ー	ー	ー	ー	－	16	Aug 7, 2024	J-GAAP
Apr - Sep, 2024 Results	139,082	17,791	18,590	12,921	56.6	16	Nov 13, 2024	J-GAAP
Revision Rate	－	－	－	－	－

Current Period Guidance

Second Half Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2023	142,971	19,082	19,756	14,342	62.9	15	May 13, 2024	J-GAAP
Oct - Mar, 2024 Guidance	180,918	25,409	25,610	19,279	84.5	17	Nov 13, 2024	J-GAAP
YoY	+26.5%	+33.2%	+29.6%	+34.4%	+34.4%

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2023	238,664	33,959	35,568	26,377	115.6	22	May 12, 2023	J-GAAP
Mar, 2024	270,840	40,048	42,434	30,936	135.6	27	May 13, 2024	J-GAAP
Mar, 2025 Guidance	320,000	43,200	44,200	32,200	141.1	33	Aug 7, 2024	J-GAAP
YoY	+18.2%	+7.9%	+4.2%	+4.1%	+4.1%

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Jul - Sep, 2023	66,698	9,674	10,436	7,504	32.9	14.5	Nov 10, 2023	J-GAAP
Oct - Dec, 2023	73,294	14,296	14,569	9,563	41.9	19.5	Feb 9, 2024	J-GAAP
Jan - Mar, 2024	69,677	4,786	5,187	4,779	21.0	6.9	May 13, 2024	J-GAAP
Apr - Jun, 2024	68,356	11,790	12,273	8,482	37.2	17.2	Aug 7, 2024	J-GAAP
Jul - Sep, 2024	70,726	6,001	6,317	4,439	19.5	8.5	Nov 13, 2024	J-GAAP
YoY	+6.0%	-38.0%	-39.5%	-40.8%	-40.8%